EBS

Biotechnology EBS Petri Dish Reports Uncategorized

Emergent BioSolutions Earnings: Revenue, Margins, And GAAP Losses Paint A Mixed Picture

Feb 28, 2026

Biotechnology EBS Uncategorized

Emergent BioSolutions plummets on weak 2026 revenue guidance, Q4 results

Feb 27, 2026

Biotechnology EBS Uncategorized

Emergent BioSolutions authorizes $50 million stock repurchase program

Feb 26, 2026